Q32 Bio Inc (NASDAQ:QTTB) has a beta value of -0.45 and has seen 1.86 million shares traded in the last trading session. The company, currently valued at $39.24M, closed the last trade at $3.70 per share which meant it lost -$0.55 on the day or -12.94% during that session. The QTTB stock price is -1353.78% off its 52-week high price of $53.79 and -12.7% below the 52-week low of $4.17. If we look at the company’s 10-day average daily trading volume, we find that it stood at 0.89 million shares traded. The 3-month trading volume is 197.87K shares.
The consensus among analysts is that Q32 Bio Inc (QTTB) is Buy stock at the moment, with a recommendation rating of 1.80. 0 analysts rate the stock as a Sell, while 0 rate it as Overweight. 0 out of 2 have rated it as a Hold, with 2 advising it as a Buy. 0 have rated the stock as Underweight.
Q32 Bio Inc (NASDAQ:QTTB) trade information
Sporting -12.94% in the red in last session, the stock has traded in the red over the last five days, with the highest price hit on recent trading when the QTTB stock price touched $3.70 or saw a rise of 86.6%. Year-to-date, Q32 Bio Inc shares have moved -66.19%, while the 5-day performance has seen it change -85.73%. Over the past 30 days, the shares of Q32 Bio Inc (NASDAQ:QTTB) have changed -90.69%. Short interest in the company has seen 0.72 million shares shorted with days to cover at 6.74.
Wall Street analysts have a consensus price target for the stock at $80, which means that the shares’ value could jump 95.38% from current levels. The projected low price target is $64.0 while the price target rests at a high of $95.0. In that case, then, we find that the current price level is -2467.57% off the targeted high while a plunge would see the stock gain -1629.73% from current levels.
Q32 Bio Inc (QTTB) estimates and forecasts
Figures show that Q32 Bio Inc shares have outperformed across the wider relevant industry. The company’s shares have lost -80.12% over the past 6 months, with this year growth rate of 83.20%, compared to 16.90% for the industry.
If we evaluate the company’s growth over the last 5-year and for the next 5-year period, we find that annual earnings growth was -0.07% over the past 5 years. Earnings growth for 2024 is a modest 25.44% while over the next 5 years, the company’s earnings are expected to decrease by -9.40%.
QTTB Dividends
Q32 Bio Inc is expected to release its next earnings report in January this year, and investors are excited at the prospect of better dividends despite the company’s debt issue.
Also the top two Mutual Funds that are holding company’s shares are Fidelity Select Portfolios – Biotechnology and Fidelity Advisor Biotechnology Fund . As of Oct 31, 2024 , the former fund manager holds about 2.13% shares in the company for having 259.9 shares of worth $0.96 million while later fund manager owns 201.68 shares of worth $0.75 million as of Oct 31, 2024 , which makes it owner of about 1.66% of company’s outstanding stock.
